Cargando…

Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis

BACKGROUND: Hepatitis E virus (HEV) infection is responsible for inflammatory liver disease and can cause severe health problems. Because the seroprevalence of HEV varies within different population groups and between regions of the continent, we conducted a systematic review on the topic in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Villalobos, Nathalie Verónica, Kessel, Barbora, Rodiah, Isti, Ott, Jördis Jennifer, Lange, Berit, Krause, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159553/
https://www.ncbi.nlm.nih.gov/pubmed/35648773
http://dx.doi.org/10.1371/journal.pone.0269253
_version_ 1784719076193468416
author Fernández Villalobos, Nathalie Verónica
Kessel, Barbora
Rodiah, Isti
Ott, Jördis Jennifer
Lange, Berit
Krause, Gérard
author_facet Fernández Villalobos, Nathalie Verónica
Kessel, Barbora
Rodiah, Isti
Ott, Jördis Jennifer
Lange, Berit
Krause, Gérard
author_sort Fernández Villalobos, Nathalie Verónica
collection PubMed
description BACKGROUND: Hepatitis E virus (HEV) infection is responsible for inflammatory liver disease and can cause severe health problems. Because the seroprevalence of HEV varies within different population groups and between regions of the continent, we conducted a systematic review on the topic in order to provide evidence for targeted prevention strategies. METHODS: We performed a systematic review in PubMed, SCIELO, LILACS, EBSCO, and Cochrane Library and included reports up to 25 May 2021 (PROSPERO registration number: CRD42020173934). We assessed the risk of bias, publication bias, and heterogeneity between studies and conducted a random-effect meta-analysis for proportions using a (binomial-normal) generalized linear mixed model (GLMM) fitted by Maximum Likelihood (ML). We also reported other characteristics like genotype and risk factors. RESULTS: Of 1212 identified records, 142 fulfilled the inclusion criteria and were included in the qualitative analysis and 132 in the quantitative analysis. Our random-effects GLMM pooled overall estimate for past infection (IgG) was 7.7% (95% CI 6.4%–9.2%) with high heterogeneity (I(2) = 97%). We found higher seroprevalence in certain population groups, for example in people with pig related exposure for IgG (ranges from 6.2%–28% and pooled estimate of 13.8%, 95% CI: 7.6%–23.6%), or with diagnosed or suspected acute viral hepatitis for IgM (ranges from 0.3%–23.9% and pooled estimate of 5.5%, 95% CI: 2.0%–14.1%). Increasing age, contact with pigs and meat products, and low socioeconomic conditions are the main risk factors for HEV infection. Genotype 1 and 3 were documented across the region. CONCLUSION: HEV seroprevalence estimates demonstrated high variability within the Americas. There are population groups with higher seroprevalence and reported risk factors for HEV infection that need to be prioritized for further research. Due to human transmission and zoonotic infections in the region, preventive strategies should include water sanitation, occupational health, and food safety.
format Online
Article
Text
id pubmed-9159553
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91595532022-06-02 Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis Fernández Villalobos, Nathalie Verónica Kessel, Barbora Rodiah, Isti Ott, Jördis Jennifer Lange, Berit Krause, Gérard PLoS One Research Article BACKGROUND: Hepatitis E virus (HEV) infection is responsible for inflammatory liver disease and can cause severe health problems. Because the seroprevalence of HEV varies within different population groups and between regions of the continent, we conducted a systematic review on the topic in order to provide evidence for targeted prevention strategies. METHODS: We performed a systematic review in PubMed, SCIELO, LILACS, EBSCO, and Cochrane Library and included reports up to 25 May 2021 (PROSPERO registration number: CRD42020173934). We assessed the risk of bias, publication bias, and heterogeneity between studies and conducted a random-effect meta-analysis for proportions using a (binomial-normal) generalized linear mixed model (GLMM) fitted by Maximum Likelihood (ML). We also reported other characteristics like genotype and risk factors. RESULTS: Of 1212 identified records, 142 fulfilled the inclusion criteria and were included in the qualitative analysis and 132 in the quantitative analysis. Our random-effects GLMM pooled overall estimate for past infection (IgG) was 7.7% (95% CI 6.4%–9.2%) with high heterogeneity (I(2) = 97%). We found higher seroprevalence in certain population groups, for example in people with pig related exposure for IgG (ranges from 6.2%–28% and pooled estimate of 13.8%, 95% CI: 7.6%–23.6%), or with diagnosed or suspected acute viral hepatitis for IgM (ranges from 0.3%–23.9% and pooled estimate of 5.5%, 95% CI: 2.0%–14.1%). Increasing age, contact with pigs and meat products, and low socioeconomic conditions are the main risk factors for HEV infection. Genotype 1 and 3 were documented across the region. CONCLUSION: HEV seroprevalence estimates demonstrated high variability within the Americas. There are population groups with higher seroprevalence and reported risk factors for HEV infection that need to be prioritized for further research. Due to human transmission and zoonotic infections in the region, preventive strategies should include water sanitation, occupational health, and food safety. Public Library of Science 2022-06-01 /pmc/articles/PMC9159553/ /pubmed/35648773 http://dx.doi.org/10.1371/journal.pone.0269253 Text en © 2022 Fernández Villalobos et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fernández Villalobos, Nathalie Verónica
Kessel, Barbora
Rodiah, Isti
Ott, Jördis Jennifer
Lange, Berit
Krause, Gérard
Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title_full Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title_fullStr Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title_full_unstemmed Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title_short Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis
title_sort seroprevalence of hepatitis e virus infection in the americas: estimates from a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159553/
https://www.ncbi.nlm.nih.gov/pubmed/35648773
http://dx.doi.org/10.1371/journal.pone.0269253
work_keys_str_mv AT fernandezvillalobosnathalieveronica seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis
AT kesselbarbora seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis
AT rodiahisti seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis
AT ottjordisjennifer seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis
AT langeberit seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis
AT krausegerard seroprevalenceofhepatitisevirusinfectionintheamericasestimatesfromasystematicreviewandmetaanalysis